Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin

Cancer Letters

Volumn 137, Issue 2, 1999, Pages 173-181

  Stanley, L A ^a   Mandel, H G ^b   Riley, J ^c   Sinha, S ^d   Higginson, F M ^c   Judah, D J ^c   Neal, G E ^c  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Aflatoxin B1; p53 gene; ras genes

Indexed keywords

AFLATOXIN B1; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; MUTATION; NONHUMAN; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

3T3 CELLS; AFLATOXIN B1; ANIMALS; BLOTTING, SOUTHERN; CARCINOGENICITY TESTS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; EPITHELIAL CELLS; GENES, P53; GENES, RAS; LIVER; MALE; MICE; MICE, NUDE; MUTAGENS; MUTATION; RATS; RATS, INBRED F344; SEQUENCE ANALYSIS, DNA; TRANSFECTION;

EID: 0032900712     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00354-1     Document Type: Article

References (22)

1. Aguilar F., Hussain S.P., Cerutti P. Aflatoxin B1 induces the transversion of G?→T in codon 249 of the p53 tumor suppresser gene in human hepatocytes. Proc. Natl. Acad Sci. USA. 90:1992;8586-8590.
2. Aguilar F., Harris C.C., Sun T., Hollstein M., Cerutti P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science. 264:1994;1317-1319.
3. Bauer-Hofmann R., Buchmann A., Wright A.S., Schwarz M. Mutations in the H-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse. Carcinogenesis. 11:1990;1875-1877.
4. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature (London). 350:1991;429-431.
5. Davis L., Kuehl M., Battey J.F. Calcium phosphate transfection of non-adherent and adherent cells. Basic Methods in Molecular Biology. 1994;Appleston and Lange, Norwalk, CT. pp. 624-629.
6. Fujimoto Y., Hampton L.L., Luo L.D., Wirth P.J., Thorgeirsson S.S. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in non-human primates. Cancer Res. 52:1992;1044-1046.
7. Hall A.J., Wild C.P. Epidemiology of aflatoxin-related disease. Eaton D.J., Groopman J.D. The Toxicology of Aflatoxins. Human Health, Veterinary, and Agricultural Significance. 1994;233 Academic Press, New York.
8. Hollstein M., Sidransky D., Volgelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
9. Hsu I.C., Metcalf R.A., Sun T., Welsh J.A., Wang N.J., Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (London). 350:1991;427-428.
10. Hulla J.E., Chen Z.Y., Eaton D.L. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site specific mutation within the p53 gene. Cancer Res. 53:1993;9-11.
11. Lord P.G., Hardaker K.J., Loughlin J.M., Marsden A.M., Orton T.C. Point mutation analysis of ras genes in spontaneously and chemically induced C57Bl/10J mouse liver tumours. Carcinogenesis. 13:1992;1383-1387.
12. 1-induced rat liver tumors. Proc. Natl. Acad. Sci. USA. 87:1990;1104-1108.
13. Montesano R., Hainaut P., Wild C.P. Hepatocellular carcinoma: from gene to public health. J. Natl. Cancer Inst. 89:1997;1844-1851.
14. Peers F., Bosch X., Kaldor J., Linsell A., Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland, Int. J. Cancer. 39:1987;545-553.
15. 1. Carcinogenesis. 18:1997;905-910.
16. Sinha S., Marshall C.J., Neal G.E. Gamma glutamyl transpeptidase and the ras-induced transformation of a rat liver cell line. Cancer Res. 46:1986;1440-1445.
17. Sinha S., Webber C., Marshall C.J., Knowles M.A., Procter A., Barrass N.C., Neal G.E. Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. Proc. Natl. Acad. Sci. USA. 85:1988;3673-3677.
18. Skilleter D.N., Mattocks A.R., Neal G.E. Sensitivity of different phases of the cell cycle to selected hepatotoxins in cultured liver-derived (BL9L) cells. Xenobiotica. 18:1988;699-705.
19. 1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophorosis. Proc. Natl. Acad. Sci. USA. 90:1993;2045-2049.
20. Stanley L.A., Devereux T.R., Foley J., Lord P.G., Maronpot R.R., Orton T.C., Anderson M.W. Proto-oncogene activation in liver tumours of hepatocarcinogenesis-resistant strains of mice. Carcinogenesis. 13:1992;2427-2433.
21. Stanley L.A. Molecular aspects of chemical carcinogenesis. The roles of oncogenes and tumour suppresser genes. Toxicology. 96:1995;173-194.
22. Wiseman R.W., Stowers S.J., Miller E.C., Anderson M.W., Miller J.A. Activating mutations of the c-Ha-ras protooncogene in chemically-induced hepatomas of the male B6C3 F1 mouse. Proc. Natl. Acad. Sci. USA. 83:1986;5825-5829.